• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks

firstwordpharmaJuly 12, 2021

Tag: OMT , COVID-19 , Vaccine

The Netherlands' Outbreak Management Team (OMT) expressed doubts about whether Johnson & Johnson's single-dose COVID-19 vaccine offers sufficient protection against the Delta variant, reported NL Times.

OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks

"It is still questionable to what extent it indeed offers full immunity against the Delta variant 14 days after vaccination," the OMT commented, according to the ANP.

The OMT emphasized that the majority of young people follow coronavirus regulations.

According to the group, the tightened measures must be maintained until mid-August, when everyone has been vaccinated at least once.


Previous:Japan releases study on 'Moderna arm' reaction

Next:COVID-19 vaccines highly effective in most people in clinical risk groups

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Meningococcal Conjugate Vaccine (Group A+C), Freeze Dried

Meningococcal Conjugate Vaccine (Group A+C), Freeze Dried
High-dose trivalent influenza vaccine

High-dose trivalent influenza vaccine
Ruminant Vaccine Series

Ruminant Vaccine Series
Hualan Biological Influenza Vaccine

Hualan Biological Influenza Vaccine
Influenza Vaccine in 2022

Influenza Vaccine in 2022
Cheap Influenza Vaccine

Cheap Influenza Vaccine
Influenza Vaccine in Syringe Form

Influenza Vaccine in Syringe Form
Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)

Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)
Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio

Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio
High-standard and high quality Influenza Vaccine (Split virion), inactivated

High-standard and high quality Influenza Vaccine (Split virion), inactivated

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service